GI EndoChoice Holdings Inc

ENDOCHOICE HOLDINGS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout

Rigrodsky & Long, P.A.:

  • Do you own shares of EndoChoice Holdings, Inc. (NYSE: GI)?
  • Did you purchase any of your shares prior to September 27, 2016?
  • Do you think the proposed buyout price is too low?
  • Do you want to discuss your rights?

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of EndoChoice Holdings, Inc. (“EndoChoice” or the “Company”) (NYSE: GI) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by Boston Scientific Corporation (“Boston Scientific”) (NYSE: BSX), in a transaction valued at approximately $210 million.

Click here to learn more: http://rigrodskylong.com/investigations/endochoice-holdings-inc-gi.

Under the terms of the agreement, shareholders of EndoChoice will receive $8.00 in cash for each share of EndoChoice common stock.

The investigation concerns whether EndoChoice’s board of directors failed to adequately shop the Company and obtain the best possible value for EndoChoice shareholders before entering into an agreement with Boston Scientific.

If you own the common stock of EndoChoice and purchased your shares before September 27, 2016, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Seth D. Rigrodsky or Gina M. Serra at Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE 19803, by telephone at (888) 969-4242; by e-mail to [email protected], or at: http://rigrodskylong.com/investigations/endochoice-holdings-inc-gi.

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly prosecutes securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, on behalf of shareholders in states and federal courts throughout the United States.

Attorney advertising. Prior results do not guarantee a similar outcome.

EN
27/09/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on EndoChoice Holdings Inc

Ford Equity US Rating and Forecast Report

Ford Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.

 PRESS RELEASE

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Pr...

STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of EndoChoice Holdings, Inc. (NYSE: GI) (“EndoChoice” or the “Company”) relating to the proposed buyout of EndoChoice by Boston Scientific Corporation. Under the terms of the agreement, EndoChoice shareholders are anticipated to receive $8.00 in cash for each share of EndoChoice commo...

 PRESS RELEASE

ENDOCHOICE HOLDINGS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willi...

DALLAS--(BUSINESS WIRE)-- Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of EndoChoice Holdings, Inc. (“EndoChoice”) (NYSE: GI) concerning the acquisition by Boston Scientific Corporation. Under the terms of the agreement, valued at approximately $210 million, EndoChoice shareholders will only receive $8.00 per EndoChoice share owned. The consideration is significantly lower than at...

 PRESS RELEASE

ENDOCHOICE HOLDINGS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. An...

WILMINGTON, Del.--(BUSINESS WIRE)-- Rigrodsky & Long, P.A.: Do you own shares of EndoChoice Holdings, Inc. (NYSE: GI)? Did you purchase any of your shares prior to September 27, 2016? Do you think the proposed buyout price is too low? Do you want to discuss your rights? Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of EndoChoice Holdings, Inc. (“EndoChoice” or the “Company”) (NYSE: GI)...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch